Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Samsung Electronics | 1.93% | $710.06M | $812.49B | 224.72% | ― | |
| ASML Holding NV | 1.72% | $631.02M | €450.89B | 82.31% | 76 Outperform | |
| Novartis AG | 0.97% | $358.11M | CHF229.98B | 24.67% | 80 Outperform | |
| AstraZeneca | 0.95% | $349.88M | $297.58B | 20.89% | 80 Outperform | |
| Roche Holding AG | 0.92% | $338.23M | CHF254.35B | 25.81% | 73 Outperform | |
| HSBC Holdings | 0.90% | $329.32M | £205.38B | 40.17% | 80 Outperform | |
| Nestlé SA | 0.87% | $318.96M | CHF202.39B | 2.00% | 71 Outperform | |
| Toyota Motor | 0.87% | $317.90M | ¥45.19T | 26.07% | 80 Outperform | |
| Shell (UK) | 0.85% | $311.01M | £187.41B | 27.85% | 73 Outperform | |
| Royal Bank Of Canada | 0.74% | $271.54M | $227.57B | 49.77% | 75 Outperform |